These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 12497008

  • 1. Adenocarcinoma of the prostate: an expensive way to die.
    Piper NY, Kusada L, Lance R, Foley J, Moul J, Seay T.
    Prostate Cancer Prostatic Dis; 2002; 5(2):164-6. PubMed ID: 12497008
    [Abstract] [Full Text] [Related]

  • 2. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma.
    Brandeis J, Pashos CL, Henning JM, Litwin MS.
    Cancer; 2000 Oct 15; 89(8):1792-9. PubMed ID: 11042575
    [Abstract] [Full Text] [Related]

  • 3. Technological changes in the management of prostate cancer result in increased healthcare costs--a retrospective study in a defined Swedish population.
    Sennfält K, Carlsson P, Thorfinn J, Frisk J, Henriksson M, Varenhorst E.
    Scand J Urol Nephrol; 2003 Oct 15; 37(3):226-31. PubMed ID: 12775282
    [Abstract] [Full Text] [Related]

  • 4. Cumulative cost pattern comparison of prostate cancer treatments.
    Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR.
    Cancer; 2007 Feb 01; 109(3):518-27. PubMed ID: 17186528
    [Abstract] [Full Text] [Related]

  • 5. The economic burden of prostate cancer, California, 1998.
    Max W, Rice DP, Sung HY, Michel M, Breuer W, Zhang X.
    Cancer; 2002 Jun 01; 94(11):2906-13. PubMed ID: 12115378
    [Abstract] [Full Text] [Related]

  • 6. Health related quality of life and direct medical care cost in newly diagnosed younger men with prostate cancer.
    Jayadevappa R, Bloom BS, Chhatre S, Fomberstein KM, Wein AJ, Malkowicz SB.
    J Urol; 2005 Sep 01; 174(3):1059-64; discussion 1064. PubMed ID: 16094058
    [Abstract] [Full Text] [Related]

  • 7. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR, CaPSURE Investigators.
    Cancer; 2006 Apr 15; 106(8):1708-14. PubMed ID: 16544313
    [Abstract] [Full Text] [Related]

  • 8. Prostate cancer--prevalence-based healthcare costs.
    Norlund A, Alvegård T, Lithman T, Merlo J, Noreen D.
    Scand J Urol Nephrol; 2003 Apr 15; 37(5):371-5. PubMed ID: 14594683
    [Abstract] [Full Text] [Related]

  • 9. Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience.
    Mouraviev V, Nosnik I, Sun L, Robertson CN, Walther P, Albala D, Moul JW, Polascik TJ.
    Urology; 2007 Feb 15; 69(2):311-4. PubMed ID: 17320670
    [Abstract] [Full Text] [Related]

  • 10. [Prostatic cancer: an expensive dilemma].
    Borre M, Nerstrøm B, Overgaard J.
    Ugeskr Laeger; 1997 Apr 21; 159(17):2534-7. PubMed ID: 9182381
    [Abstract] [Full Text] [Related]

  • 11. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
    Poon I, Pintilie M, Potvin M, McGowan T.
    Can J Urol; 2004 Feb 21; 11(1):2125-32. PubMed ID: 15003151
    [Abstract] [Full Text] [Related]

  • 12. Goserelin (Zoladex) or orchiectomy in metastatic prostate cancer? A quality of life and cost-effectiveness analysis.
    Nygård R, Norum J, Due J.
    Anticancer Res; 2001 Feb 21; 21(1B):781-8. PubMed ID: 11299844
    [Abstract] [Full Text] [Related]

  • 13. Early outcomes of active surveillance for localized prostate cancer.
    Hardie C, Parker C, Norman A, Eeles R, Horwich A, Huddart R, Dearnaley D.
    BJU Int; 2005 May 21; 95(7):956-60. PubMed ID: 15839912
    [Abstract] [Full Text] [Related]

  • 14. Cost comparison of radical retropubic and radical perineal prostatectomy: single institution experience.
    Silverstein AD, Weizer AZ, Dowell JM, Auge BK, Paulson DF, Dahm P.
    Urology; 2004 Apr 21; 63(4):746-50. PubMed ID: 15072893
    [Abstract] [Full Text] [Related]

  • 15. Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10).
    Konski A, Sherman E, Krahn M, Bremner K, Beck JR, Watkins-Bruner D, Pilepich M.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):788-94. PubMed ID: 16109464
    [Abstract] [Full Text] [Related]

  • 16. Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer.
    Miyake H, Sakai I, Harada K, Hara I, Eto H.
    Int J Urol; 2004 Jun 01; 11(6):397-401. PubMed ID: 15157209
    [Abstract] [Full Text] [Related]

  • 17. A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer.
    Crawford ED, Black L, Eaddy M, Kruep EJ.
    Prostate Cancer Prostatic Dis; 2010 Jun 01; 13(2):162-7. PubMed ID: 20125121
    [Abstract] [Full Text] [Related]

  • 18. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H.
    BJU Int; 2005 Apr 01; 95(6):751-6. PubMed ID: 15794776
    [Abstract] [Full Text] [Related]

  • 19. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.
    D'Amico A.
    BJU Int; 2007 Jan 01; 99 Suppl 1():13-6; discussion 17-8. PubMed ID: 17229162
    [Abstract] [Full Text] [Related]

  • 20. The burden of out-of-pocket and indirect costs of prostate cancer.
    Jayadevappa R, Schwartz JS, Chhatre S, Gallo JJ, Wein AJ, Malkowicz SB.
    Prostate; 2010 Aug 01; 70(11):1255-64. PubMed ID: 20658653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.